Akcea Therapeutics Inc. (AKCA) shares are trading at higher $18.28 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $22.79 and the low is $8.00. Over the last 52 weeks, AKCA is down -13.20% while the S&P 500 is up 19.44%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, AKCA reported a profit of $17.33 million. Akcea Therapeutics Inc. also saw revenues increase to $22.38 million. In addition, AKCA has free cash flow of -$78.09 million as of 06-2020. The company’s EBITDA came in at -$48.76 million which compares well with its peers.
AKCA booked profit margins of -12.30%, its Return on Equity (ROE) is -8.90%, and its Return on Assets is -8.00%. All told, it is clear that, AKCA needs to be on your watchlist.
Find out when AKCA reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. AKCA has a short ratio of 11.04 and outstanding shares of 77.10M.
Company Outlook
AKCA has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -0.85. Akcea Therapeutics Inc. AKCA also noted assets of $527.94 million at the end of the last quarter. Investors should also keep an eye on sector updates as AKCA has historically followed its peers on positive news.
All told, Akcea Therapeutics Inc. AKCA has strung together solid data and demonstrated underlying fundamentals. At its current valuation, AKCA represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Akcea Therapeutics Inc. AKCA is now commanding a market cap of 1.92B and a float of 17.40M. AKCA is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of AKCA stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in AKCA, either long or short, and we have not been compensated for this article.